147 related articles for article (PubMed ID: 21786035)
1. The use of a human papillomavirus 18 promoter for tissue-specific expression in cervical carcinoma cells.
Lung MS; Mak WM; Murray V
Cell Mol Biol Lett; 2011 Sep; 16(3):477-92. PubMed ID: 21786035
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of human papillomavirus 18 promoter elements and tissue-specific expression in cervical carcinoma cells.
Lung MS; Zhang N; Murray V
Virus Genes; 2012 Jun; 44(3):395-402. PubMed ID: 22350992
[TBL] [Abstract][Full Text] [Related]
3. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
4. HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer.
Amaro-Filho SM; Pereira Chaves CB; Felix SP; Basto DL; de Almeida LM; Moreira MAM
Papillomavirus Res; 2018 Jun; 5():172-179. PubMed ID: 29649654
[TBL] [Abstract][Full Text] [Related]
5. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
6. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
7. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
[TBL] [Abstract][Full Text] [Related]
8. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
9. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
[TBL] [Abstract][Full Text] [Related]
10. Identification of a promoter in position 56 within the long control region of human papillomavirus type 18.
Steger G; Rehtanz M; Schnabel C
Arch Virol; 2001; 146(11):2069-84. PubMed ID: 11765912
[TBL] [Abstract][Full Text] [Related]
11. hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis.
de Wilde J; Kooter JM; Overmeer RM; Claassen-Kramer D; Meijer CJ; Snijders PJ; Steenbergen RD
BMC Cancer; 2010 Jun; 10():271. PubMed ID: 20534141
[TBL] [Abstract][Full Text] [Related]
12. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
13. Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variants.
Amador-Molina A; González-Montoya JL; García-Carrancá A; Mohar A; Lizano M
J Gen Virol; 2013 Feb; 94(Pt 2):393-402. PubMed ID: 23100366
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
16. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies.
Kozuka T; Aoki Y; Nakagawa K; Ohtomo K; Yoshikawa H; Matsumoto K; Yoshiike K; Kanda T
Jpn J Cancer Res; 2000 Mar; 91(3):271-9. PubMed ID: 10760685
[TBL] [Abstract][Full Text] [Related]
17. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
18. Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants.
López-Saavedra A; González-Maya L; Ponce-de-León S; García-Carrancá A; Mohar A; Lizano M
Arch Virol; 2009; 154(5):747-54. PubMed ID: 19337781
[TBL] [Abstract][Full Text] [Related]
19. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
20. Tip60 and p300 function antagonistically in the epigenetic regulation of HPV18 E6/E7 genes in cervical cancer HeLa cells.
Lai Y; He Z; Zhang A; Yan Z; Zhang X; Hu S; Wang N; He H
Genes Genomics; 2020 Jun; 42(6):691-698. PubMed ID: 32399935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]